Obesity and progression of chronic renal insufficiency: A Czech long term prospective double-blind randomised multicentre study;Obezita a progrese chronické renální insuficience: Česká dlouhodobá prospektivní randomizovaná dvojitě slepá multicentrická studie

Vnitrni Lekarstvi

Volumn 52, Issue 6, 2006, Pages 571-576

  Teplan, V ^a,b   Schuck O ^a,b   Hanzal, V ^a   Hajny J ^c   Horackova M ^d   Ryba, M ^c   Stanek I ^e   Surel S ^f   Bret, M ^c   Stollova M ^a   Sasakova D ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b IPVZ   (Czech Republic)

^c HDS Chrudim ^*  (Philippines)

^d UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^e Interní Odd lení Nemocnice eské Bud jovice   (Czech Republic)

^f UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Keto amino acids; Obesity; Progression; Renal insufficiency

Indexed keywords

ALBUMIN; GLUCOSE; LEPTIN; LEUCINE; OXOAMINO ACID; PLACEBO; TRANSFERRIN; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBESITY; PROTEIN RESTRICTION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; AGED; AMINO ACIDS, ESSENTIAL; DIET, PROTEIN-RESTRICTED; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OBESITY;

EID: 33745747927     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lachmanová J. Statistická ročenka dialyzační léčby v České republice. Praha: Česká nefrologická společnost 2004.
2. Praga M. Obesity - a neglected culprit in renal disease. Nephrol Dial Transpl 2002; 17: 1157-1159.
3. Kambham N, Markowitz GS, Valeri AM et al. Obesity - related glomerulopathy: An emerging epidemic. Kidney Int 2001; 59: 1498-1509.
4. Klassen A, Sebekova K, Heidland A et al. Obesity - a neglected risk factor of the Kidney. Nieren und Hochdruckkrankheiten 2003; 32: 189-196.
5. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112: 1785-1788.
6. Agnami S, Vachharajani VT, Gupta R et al. Does treating obesity stabilize chronic kidney disease? BMC Nephrology 2005; 6: 1-4.
7. Pelikánová T. Metabolický syndrom. Vnitř Lék 2003; 49: 900-906.
8. Wiecek A, Kokot F, Chudek J et al. The adipose tissue - a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transpl 2002; 17: 191-195.
9. Axelsson J, Heimbrger O, Lindholm B et al. Adipose tissue and its relation to inflammation the role of adipokines. J Renal Nutr 2005; 15: 131-136.
10. Stenvinkel P, Marchlewska A, Pecoits-Filho R et al. Adiponectin in renal disease: Relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 2004; 65: 274-281.
11. Andrlová K, Haluzík M. Tuková tkáň a insulinová rezistence. Diab Met Endrokrin Výživa 2005; 8: 87-96.
12. Zoccali C, Mallamaci F, Panuccio V et al. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int 2003; 63(Suppl 84): 98-102.
13. Zoccali C, Mallamaci F, Tripetpi G. Adipose tissue as a source of inflammatory cytokines in health and disease: focus and-stage renal disease. Kidney Int 2003; 63(Suppl 84): 65-68.
14. Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role: In the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830.
15. Olšovský J. Obezita a diabetes. Vnitř Lék 2003; 49: 956-957.
16. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-1119.
17. Mitch W. Are supplements of ketoacids and amino acids useful in treating patients with chronic renal failure? Wien Klin Wocheschr 2000; 112: 863-864.
18. Teplan V, Schück O, Horačková M at al. Effect of keto acid-amino acid supplement on the metabolism and renal elimination of branched-chain amino acids in patients with chronic renal insufficiency on a low protein diet. Wien Klin Wochenschr 2000; 112: 876-881.
19. Teplan V, Schück O, Votruba M at al. Metabolic effect of keto acid-amino acid supplementation in patients with chronic renal insufficiency receiving a low-protein diet and recombinant human erythropoetin - A randomized controlled trial. Wien Klin Wochenschr 2001; 113: 661-669.
20. Teplan V, Schück O, Knotek A et al. Enhanced metabolic effect of erythropoetin and keto acids in CRF patients on low-protein diet: Czech multicenter study. Am J Kidney Dis 2003; 41: Suppl 1: 26-30.
21. Di Iorio BR, Minutolo R, de Nicola LD et al. Supplemented very low protein diet ameliorates responsiveness to erythropoetin in chronic renal failure. Kidney Int 2003; 64: 1822-1828.
22. Meloni C, Taangelo P, Cipriani S et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. J Ren Nutr 2004; 14: 208-213.
23. Prakash S, Prasad Pande D, Sharma S et al. Randomized, double-blind, placebo-controlled trial to evaluate efficacy of keto diet in predialytic chronic renal failure. J Ren Nutr 2004; 14: 89-96.
24. Teplan V. Pharmacological features of keto amino acid therapy. Am J Nephrol 2005; 25(Suppl 1): 13-14.
25. Chauveau P, Vendrely B, Haggan W et al. Body composition of patients on a very low-protein diet: a two-year survey with DEXA. J. Ren Nutr 2003; 4: 282-287.
26. Schück O, Teplan V, Štollová M et al. Estimation of glomerular filtration rate in obese patients with chronic renal impairment based on serum cystatin C levels. Clin Nephrol 2004; 62: 92-96.
27. Clinical Practice guidelines for chronic kidney disease (K/DOQI) National Kidney Foundation. New York 2002.
28. Schück O, Smrčková J, Teplan V et al. Nová metoda stanovení glomerulární filtrace na podkladě sérové koncentrace kreatininu, močoviny a albumimu (MDRD). Vnitř Lék 2004; 50: 507-509.